Sign In

Deborah Sneddon

Postdoctoral Researcher at University of Oxford

Deborah Sneddon is a Postdoctoral Researcher affiliated with the University of Oxford, specifically at the MRC Oxford Institute for Radiation Oncology within the Department of Oncology. Her research focuses on the development of novel chelators for nuclear imaging, which are crucial for directing radiometals to specific targets in medical imaging applications such as PET and MRI.1

Academic Background and Research

Deborah joined the redOx⇌KCL team in October 2019, where she has been involved in creating new contrast agents that enhance imaging capabilities.3 Her work includes exploring innovative compounds that can improve the stability and efficacy of imaging agents used in clinical settings.1

Publications and Contributions

She has authored several publications, contributing significantly to the field of radiopharmaceuticals and imaging technologies. Her recent research includes the development of multimodal imaging platforms, which aim to integrate various imaging techniques for better diagnostic outcomes.26

Current Position

As a postdoctoral researcher, Deborah continues to advance her research at the University of Oxford while also engaging in teaching and mentoring activities within her department. She is recognized for her contributions to both academia and practical applications in nuclear medicine.45

In summary, Deborah Sneddon is an accomplished researcher whose work is pivotal in enhancing nuclear imaging techniques, thereby impacting diagnostic medicine.

Related Questions

What are Deborah Sneddon's main research interests?
How has Deborah Sneddon contributed to the field of nuclear imaging?
What projects is Deborah Sneddon currently working on at the University of Oxford?
Can you provide more details about Deborah Sneddon's work on novel multimodal imaging platforms?
What is Deborah Sneddon's educational background?
Deborah Sneddon
Add to my network

Location

Greater Oxford Area